期刊文献+

拮抗miR-21对人工合成高效孕激素作用下子宫内膜癌细胞增殖和凋亡的影响 被引量:3

Effect of antagonistic miR-21 combined with synthetic high-efficiency progesterone on the proliferation and apoptosis of endometrial cancer cells
下载PDF
导出
摘要 目的探讨拮抗miR-21联合人工合成高效孕激素对子宫内膜癌Ishikawa细胞增殖、凋亡的影响。方法采用流式细胞法、细胞计数法(CCK-8)、Transwell实验及划痕实验检测各组Ishikawa细胞的凋亡、增殖、侵袭及迁移能力;实验分为两组。空白细胞组:未经任何处理的子宫内膜Ishikawa细胞;高效孕激素组:经人工合成高效孕激素处理的子宫内膜Ishikawa细胞;高效孕激素+miR-21组:经人工合成高效孕激素和miR-21拮抗剂共同处理的子宫内膜Ishikawa细胞。结果干预前与干预24 h后高效孕激素组细胞增殖率、高效孕激素+miR-21组细胞增殖率比较差异有统计学意义(P<0.05);高效孕激素+miR-21组细胞增殖率与其他2组比较差异有统计学意义(P<0.05);干预前与干预24 h后高效孕激素组细胞迁移率、高效孕激素+miR-21组细胞迁移率比较差异有统计学意义(P<0.05);高效孕激素+miR-21组细胞迁移率与其他2组比较差异有统计学意义(P<0.05);干预前与干预24 h后高效孕激素组细胞侵袭力、高效孕激素+miR-21组细胞侵袭力比较差异有统计学意义(P<0.05);高效孕激素+miR-21组细胞侵袭力与其他2组比较差异有统计学意义(P<0.05);干预前与干预24 h后高效孕激素组细胞凋亡率、高效孕激素+miR-21组细胞凋亡率比较差异有统计学意义(P<0.05);高效孕激素+miR-21组细胞凋亡率与其他2组比较差异有统计学意义(P<0.05)。结论拮抗miR-21可促进人工合成高效孕激素作用下Ishikawa细胞的凋亡及抑制其增殖。 Objective To investigate the effect of antagonistic miR-21 combined with synthetic high-efficiency progesterone on the proliferation and apoptosis of endometrial cancer cells.Methods Flow cytometry,cell counting method(CCK-8),Transwell test and scratch test were used to detect the apoptosis,proliferation,invasion and migration ability of endometrial ishikawa cells.The endometrial ishikawa cells were divided into three groups,including control group(without any treatment),high-efficiency progesterone group(the cells treated with synthetic high-efficiency progesterone)and high-efficiency progesteronet combined with miR-21 group(the cells treated with synthetic high-efficiency progesterone and miR-21 antagonist).Results The cell proliferation rate of high-efficiency progesterone group was significantly different from that before intervention(P<0.05).The cell proliferation rate of high-efficiency progesterone+miR-21 group was significantly different from that before intervention(P<0.05).Compared with the other two groups,the cell proliferation rate of high efficiency progestin+miR-21 group was the lowest,and the difference was statistically significant(P<0.05).The cell migration rate of high-efficiency progestin group was significantly different from that before intervention(P<0.05).The cell migration rate of high-potency progesterone+miR-21 group was significantly different from that before intervention(P<0.05).Compared with the other two groups,the cell migration rate of high-potency progestin+miR-21 group was the lowest,and the difference was statistically significant(P<0.05).The cell invasiveness of high-efficiency progesterone group was significantly different from that before intervention(P<0.05).The invasiveness of high-potency progesterone+miR-21 group was significantly different from that before intervention(P<0.05).Compared with the other two groups,the high-potency progesterone+miR-21 group had the lowest cell invasion,and the difference was statistically significant(P<0.05).The apoptosis rate of high-efficiency progesterone group was significantly different from that before intervention(P<0.05).The apoptosis rate of high-efficiency progesterone+miR-21 group was significantly different from that before intervention(P<0.05).Compared with the other two groups,the apoptosis rate of high efficiency progestin+miR-21 group was the highest and the difference was statistically significant(P<0.05).Conclusion Antagonistic miR-21 combined with synthetic high-efficiency progesterone can promote the apoptosis and inhibit the proliferation of endometrial cancer ishikawa cells.
作者 田春花 张娇 杨梅芳 杨威龙 吴阳 金秋 马鸿云 TIAN Chunhua;ZHANG JIAO;YANG Meifang;YANG Weilong;WU Yang;JIN Qiu;MA Hongyun(People′s Hospital of Ningxia Hui Autonomous Region,Yinchuan 750002,China;Yinchuan Maternity and Child Health Care Hospital,Yinchuan 750001,China)
出处 《宁夏医学杂志》 CAS 2021年第10期865-868,共4页 Ningxia Medical Journal
基金 宁夏自然科学基金项目(2020AAC03336) 西北民族大学基金项目(31920190180) 北方民族大学2019年度校级一般科研项目(2019YXKY01) 宁夏回族自治区人民医院培育振兴科研项目(202006)。
关键词 人工高效孕激素 miR-21拮抗剂 人子宫内膜癌细胞 细胞计数法 Synthetic high-efficiency progesterone MiR-21 antagonist Endometrial cancer cells CCK-8
  • 相关文献

参考文献6

二级参考文献37

  • 1俞梅,沈铿,杨佳欣,黄惠芳,吴鸣,潘凌亚,郎景和,连利娟.高分化子宫内膜样癌及子宫内膜重度不典型增生患者孕激素治疗的临床分析[J].中华妇产科杂志,2006,41(4):242-245. 被引量:28
  • 2PARK H, SEOK J M, YOON B S, et al. Effectiveness of high- dose progestin and long-term outcomes in young women with early-stage, well-differentiated endometrioid adenocarcinoma of uterine endometrium [ J ] . Arch Gynecol Obstet, 2012, 285(2): 473-478.
  • 3NEENA P, MICHAEL T, JENNIFER S, et al. Differential Regulation of growth factors and matrix metalloproteinase-1 by estrogen, progesterone, and tamoxifen in normal and cancerous endometrial cells [J]. J Cancer Mol, 2009, 4(6): 169-173.
  • 4YAHATA T, FUJITA K, AOKI Y, et al. Long-term conservative therapy for endometrial adenocarcinoma in young women [ J ]. Hum Reprod, 2006, 21(1): 1070-1075.
  • 5PARK J C, CHO C H, RHEE J H. A successful live birth through in vitro fertilization program after conservative treatment of FIGO grade I endometrial [ J ] . J Korean Med Sci, 2006, 21(1): 567-571.
  • 6NIWA K, TAGAM! K, LIAN Z, et al. Outcome of fertility-- preserving treatment in young women with endometrial carcinomas [ J ] . BJOG, 2005, 1(1): 317-320.
  • 7BORROW C P, BUNDY B N, KU RMAN R J, et al. Relationship between surgical-pathological risk fact ors an d out come in clinical stageⅠ and Ⅱ carcinoma of the endometrium: a Gynecologic Oncology Group study [J]. Gynecol Oneol, 1991, 40(1): 55-65.
  • 8RAMIREZ P T, FRUMOVITZ M, BODURKA D C, et al. Hormonal therapy for the management of grade 1 endometrial adenocareinoma:a literature review. [ J ] . Gynecol Oncol, 2004, 95(1): 133-138.
  • 9CORMIO G, MARTINO R, LOIZZI V, et al. A rare case of ehoroidal metastasis presented after conservative management of endometrial cancer [ J ] . Int J Gynecol Cancer, 2006, 16(1): 2044-2048.
  • 10GOTLIEB W H, BEINER M E, SHALMON B, et al. Outcome of fertility-sparing treatment with progestins in young patients with endometrial cancer [ J ] . Obstet Gynecol, 2003, 102(4): 718-725.

共引文献138

同被引文献24

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部